Feb 4 (Reuters) - Cigna Corp's Express Scripts has settled the U.S. ‌Federal ​Trade Commission's claims its insulin pricing ‌practices violated antitrust and consumer protection laws, and agreed to ...

Cigna and FTC officials said their settlement would save patients several billions of dollars on insulin drugs during the ...

TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, went live on Thursday. A key pillar of ...

Experts and interested parties are digging into the pharmacy benefit manager (PBM) reform provisions that were included in the massive spending bill that President Donald Trump signed into law on Feb ...

The Genesee County Board of Commissioners voted unanimously against a recommendation to switch more than 100 retirees from ...

It’s part of Trump’s plan to lower drug prices in the US, but some experts are skeptical the platform will meaningfully ...

First, his FTC Chair, Andrew Ferguson, announced a historic deal with Cigna/Express Scripts to lower prescription drug prices ...

Mark Cuban critiques the FTC Cigna Express Scripts settlement, citing limited reforms and concerns over rebate ...

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

The Federal Trade Commission on Wednesday finalized a major settlement with Cigna Group’s CI pharmacy benefit manager Express Scripts, aimed at dismantling anticompetitive practices that have ...

1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...

The Trump administration is preparing to launch TrumpRx.com, an initiative aimed at lowering drug costs by aggregating direct-to-consumer access to branded prescription medications at discounted cash ...